Know Your Ports - Oncology Nursing News
Dec 21, 2017 · Throughout the course of treatment, many patients with cancer receive chemotherapy, intravenous fluids, antibiotics, and much more via central venous catheters …
How ctDNA Testing Is Being Used To Diagnose And Monitor Cancer
Dec 18, 2024 · “ctDNA testing looks for small pieces of DNA found in a patient’s blood that comes from cancer cells and tumors,” Grafton explains. “Screening for ctDNA can be used to detect …
Leuprolide, OCPs Manage Abnormal Uterine Bleeding in Stem Cell …
Oct 23, 2024 · For patients with hematologic malignancies undergoing treatments such as stem cell transplantation, blood transfusions are often essential due to complications like anemia …
PD-L1 CPS Score Could Direct Treatment Decisions in Recurrent ...
Apr 1, 2022 · PD-L1 combined positive score (CPS) may serve to predict whether a patient with PD-L1–expressing recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) …
ASCO Recommends Abemaciclib for High-Risk HR+, HER2- Breast …
Oct 24, 2024 · The American Society of Clinical Oncology (ASCO) recently announced guidelines outlining a preference for abemaciclib (Verzenio) over ribociclib (Kisqali) for the treatment of …
Low-Dose Tamoxifen Shows Continued Efficacy in Adjuvant …
Feb 17, 2023 · Tamoxifen, at a dose of 5 mg daily (babytam), continued to show a benefit over placebo in reducing the risk of recurrence from invasive breast cancers and ductal carcinoma …
FDA OKs Subcutaneous Nivolumab in Advanced/Metastatic Solid …
Dec 27, 2024 · The FDA granted approval to nivolumab and hyaluronidase-nvhy (Opdivo Qvantig; subcutaneous nivolumab) across approved adult solid tumor nivolumab (Opdivo) indications …
FDA Delays Decision Dates for Sotorasib and Obeticholic Acid
Oct 23, 2024 · The FDA pushed back Prescription Drug User Fee Act (PDUFA) dates for sotorasib (Lumakras) and obeticholic acid (Ocaliva) in patients with metastatic colorectal …
Advancing Multiple Myeloma Treatment With CAR T-Cell Therapy
Jul 10, 2024 · CAR T-cell therapy represents a significant advancement in the treatment of multiple myeloma, especially as its ability to provide deep and durable responses offers …
Treatment with Axatilimab in Chronic GVHD: How it Works and …
Oct 7, 2024 · Panelists discuss how axatilimab, a novel therapy for chronic graft-versus-host disease (cGVHD), functions through a unique mechanism of action compared to other …